Therapy Reports

Top rated products

• 
  Lumbar Radiculopathy (Sciatica)| Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,989.00 – $20,967.00
• 
  Acute Kidney Injury (AKI) | Primary Research (KOL’s Insight) | Competitive Intelligence | Market Analytics & Forecast 2032 $6,989.00 – $20,967.00
• 
  Metastatic Ovarian Cancer (mOC)| Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,989.00 – $20,967.00
• 
  Acute Myeloid Leukemia (AML) -The Changing Landscape of Treatment in AML, Executive Deck 2022 $5,000.00 – $25,000.00
• 
  Metastatic Renal cell carcinoma (mRCC) | Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,989.00 – $20,967.00